Abstract:A series of 6 derivatives of xanthone were synthesized and evaluated for cardiovascular activity. The following pharmacological experiments were conducted: the binding affinity for adrenoceptors, the influence on the normal electrocardiogram, the effect on the arterial blood pressure, the effect on blood pressor response and prophylactic antiarrhythmic activity in adrenaline induced model of arrhythmia (rats, iv). Two compounds revealed nanomolar affinity for α1-adrenoceptor which was correlated with the strongest cardiovascular (antiarrhythmic and hypotensive) activity in animals' models. They were enantiomers of previously described (R,S)-4-(2-hydroxy-3-(4-(2-methoxyphenyl)piperazin-1-yl)propoxy)-9H-xanthen-9-one hydrochloride and revealed similar antiarrhythmic potential in adrenaline induced model of arrhythmia in rats after intravenous injection (ED50=0.53 mg/kg and 0.81 mg/kg, respectively). These values were lower than values obtained for reference drug urapidil. These compounds were more active in this experiment than urapidil (ED50=1.26 mg/kg). The compound 5 administered iv at doses of 0.62-2.5 mg/kg at the peak of arrhythmia prevented and/or reduced the number of premature ventricular beats in a statistically significant manner. The ED50 value was 1.20 mg/kg. The S-enantiomer (6) given at the same doses did not show therapeutic antiarrhythmic activity in this model. These compounds significantly decreased the systolic and diastolic blood pressure throughout the whole observation period in anesthetized, normotensive rats. The studied enantiomers showed higher toxicity than urapidil, but imperceptibly higher that another cardiovascular drugs, that is, carvedilol or propranolol. They were also evaluated for mutagenic potential in the Ames (Salmonella) test. It was found that at the concentrations tested the compounds were non mutagenic when compared to solvent control. Results were quite promising and suggested that in the group of xanthone derivatives new potential antiarrhythmics and hypotensives might be found.

Synthesis and local anesthetic and circulatory actions of aminoesters and hydroxyamine monoterpene derivatives

Propranolol analogs containing natural monoterpene structures: synthesis and pharmacological properties

Synthesis of 4-(2-amino-1-hydroxy-ethyl)-phenol Hydrochloride

Synthesis and Pharmacological Properties of Novel Esters Based on Monoterpenoids and Glycine

Molecular structure and antiaggregating activity of the potent local anaesthetic (-)-4-[2-hydroxy-3-(N-isopropylamino)-propoxyimino]-cis-carane

Synthesis and Anesthetic Activity of Novel Coumarin Derivatives

Synthesis and Pharmacological Properties of Novel Esters Based on Monocyclic Terpenes and GABA

Structure—Activity Relationship of Local Anesthetics Based on Alkynylpiperidine Derivatives

Syntheses, Crystal Structures, and Spectroscopic Studies of Aromatic Ester Derivatives of Hexamolybdate

Design, synthesis, and activity evaluation of water-soluble propofol derivatives as anesthetic drugs

Experimental study of local anesthetic and antiarrhythmic activities of fluorinated ethynylpiperidine derivatives

Design, Synthesis and Biological Evaluation of Novel Procaine Derivatives for Intravenous Anesthesia.

Discovery of a novel series of α-terpineol derivatives as promising anti-asthmatic agents: Their design, synthesis, and biological evaluation.

Anesthetic Pharmacology of the Mint Extracts L-Carvone and Methyl Salicylate

Synthesis and Biological Activity of Novel L-Amino Acid Based Analgesic Compounds

[Comparative study of the toxicity and antiarrhythmic activity of some organic derivatives of dimethylacetamide]

Synthesis, sciatic nerve block activity evaluation and molecular docking of fluoro-substituted lidocaine analogs as local anesthetic agents

Synthesis and Biological Evaluation of a Natural Ester Sintenin and Its Synthetic Analogues

Novel Arylpiperazine Derivatives of Salicylamide with α1-Adrenolytic Properties Showed Antiarrhythmic and Hypotensive Properties in Rats

[Synthesis and Antihypertensive Activity of Some Phenoxyalkylamine Compounds].

Cardiovascular activity of the chiral xanthone derivatives